Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.
The journal invites students to share their medical training observations captured in photographs by highlighting a drawing of a DNA double helix as a symbol for the role of ethics in genetic research.